ACHE and early-onset autosomal dominant Alzheimer disease: This inhibitory capacity is relevant due to its potential application in the treatment of neurodegenerative diseases such as Alzheimer’s disease, as AChE inhibition favors the transmission of nerve signals by maintaining adequate levels of acetylcholine.